- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Novo Nordisk A/S Annual Shareholders Meeting Transcript
/- -
Good afternoon, and welcome to Novo Nordisk's Annual General Meeting 2022. We had planned for the Chair of the Board, Helge Lund, to be present with us here today. But unfortunately, due to COVID-19, Helge is unable to travel to Denmark. He joins us virtually from his home in Norway.
Helge, over to you.
/-
Thank you, Lars, and good afternoon, and a warm welcome to Novo Nordisk Annual General Meeting 2022. My name is Helge Lund, and I'm the Chair of the Board of Directors. And let me start out by expressing how thrilled I am that we are able to conduct this Annual General Meeting as a hybrid, allowing for participation irrespective of your location and preference. And on behalf of the Board, a very warm welcome to you all, and thank you for joining us.
For those of you joining us online, please note that the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |